Medicofarma Biotech SA
WSE:MDB
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.377
1.225
|
Price Target |
|
We'll email you a reminder when the closing price reaches PLN.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Medicofarma Biotech SA
Common Shares Outstanding
Medicofarma Biotech SA
Common Shares Outstanding Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
M
|
Medicofarma Biotech SA
WSE:MDB
|
Common Shares Outstanding
zł68m
|
CAGR 3-Years
116%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
I
|
Inno-Gene SA
WSE:IGN
|
Common Shares Outstanding
zł6.2m
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
R
|
Ryvu Therapeutics SA
WSE:RVU
|
Common Shares Outstanding
zł23.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
S
|
Selvita SA
WSE:SLV
|
Common Shares Outstanding
zł18.4m
|
CAGR 3-Years
9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Medicofarma Biotech SA
Glance View
Medicofarma Biotech SA is a biotechnology company, which focuses on the innovative medicine, medicinal products, and biotechnology products. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2008-11-27. The company is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.
See Also
What is Medicofarma Biotech SA's Common Shares Outstanding?
Common Shares Outstanding
68m
PLN
Based on the financial report for Dec 31, 2023, Medicofarma Biotech SA's Common Shares Outstanding amounts to 68m PLN.
What is Medicofarma Biotech SA's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
59%
Over the last year, the Common Shares Outstanding growth was 0%. The average annual Common Shares Outstanding growth rates for Medicofarma Biotech SA have been 116% over the past three years , 59% over the past five years .